Andrea Lauer

Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study

M. Gatzoulis, J. Granton, M. Landzberg, 2006, Circulation.

Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.

M. Gatzoulis, J. Granton, M. Landzberg, 2010, International journal of cardiology.

Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.

M. Gatzoulis, J. Granton, M. Landzberg, 2008, International journal of cardiology.

BREATHE-5: BOSENTAN IMPROVES HEMODYNAMICS AND EXERCISE CAPACITY IN THE FIRST RANDOMIZED PLACEBO-CONTROLLED TRIAL IN EISENMENGER PHYSIOLOGY

M. Gatzoulis, J. Granton, M. Landzberg, 2005 .

Double-Blind , Randomized , Placebo-Controlled Study Bosentan Therapy in Patients With Eisenmenger Syndrome : A Multicenter

M. Gatzoulis, J. Granton, M. Landzberg, 2006 .

Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.

M. Gatzoulis, J. Granton, M. Landzberg, 2010, International journal of cardiology.